Using Selection Biomarkers and Unraveling the Resulting Data to Drive Clinical Trial SuccessThought Leadership
Biomarkers can deliver powerful advantages to clinical trials—if they are used correctly. Chad Clark, President, Precision for Medicine; Scott Marshall, Managing Director, Translational Informatics and Diagnostic Services, Precision for Medicine; and Cliff Culver, Senior Vice President, Precision Medicine Group, share their insights in this article for the Journal of Clinical Trials.
Access the full article below.
Journal of Clinical Trials – Using selection biomarkers and unravelling
This article originally appeared in Volume 11, Issue 1 of the Journal for ClinicalStudies.